The American Academy of Pediatrics (AAP) reaffirmed its support Thursday for providing children with transgender hormones and surgeries – so-called “gender-affirming care” – at the same time it announced a review of medical research on the life-altering treatments.
The medical organization reaffirmed its 2018 position on the provision of the hormone drugs and surgeries to young people who say they are uncomfortable with their biological sex.
Detransitioner Chloe Cole appeared before a House subcommittee Thursday, testifying that transgender hormone drugs and surgeries “ruined” her childhood and left her with “lifelong irreversible harm.”
Cole, 19, who now serves as a senior fellow and patient advocate for Do No Harm, an organization that seeks to “protect patients, physicians, and healthcare itself from the practice of medicine based on discriminatory, divisive ideologies,” testified before the House Judiciary Subcommittee on Crime and Federal Government Surveillance at the hearing titled “The Dangers and Due Process Violations of ‘Gender-Affirming Care.’”
Three “detransitioners”—men who underwent surgeries in pursuit of a female gender identity but later rejected that identity—filed a legal brief supporting a Florida health agency’s rule preventing Medicaid from reimbursing for transgender medical interventions.
Florida’s Agency for Health Care Administration finalized the rule in August 2022, declaring that Medicaid would not cover “puberty blockers,” hormones, “sex reassignment” surgeries, or other procedures that alter primary or secondary sex characteristics.
A taxpayer-funded National Institutes of Health (NIH) study that drew the conclusion that teens who receive puberty blockers and cross-sex hormones have greater life satisfaction has come under fire. The study, published at the New England Journal of Medicine (NEJM), states researchers from the Lurie Children’s Hospital of Chicago sought to investigate the psychosocial functioning of 315 transgender and nonbinary young people, aged 12-20 years, over a period of two years after “gender-affirming hormones” (GAH), i.e., testosterone or estradiol, had been administered for gender dysphoria.
The Florida Board of Medicine has voted to ban puberty blockers, cross-sex hormones, and surgeries such as double mastectomies and castrations – what LGBTQ activists call “gender-affirming care” – for children under the age of 18 in the state.
The move to prohibit the life-altering hormones and surgeries for the treatment of gender dysphoria in children and teens makes the Florida medical board the first in the nation to pursue such a rule, NBC News reported Saturday.
“More trans teens are choosing ‘top surgery,’” reads a Monday New York Times headline of a story that highlights the practice of a Miami “top” surgeon who posts photos on TikTok touting her work with the phrase, “Yeet the Teet,” a reference to breast removal.
The Times uses the example of a girl, 17, who is referred to as “Michael,” posing for photos of her newly revealed chest, with breasts, and now bandages, removed, alongside her mother and her “top surgeon,” Dr. Sidhbh Gallagher, who posts the photos on her social media platforms for all her “followers” to see the results.
Young women who regretted undergoing sex changes in their adolescent years spoke about their experiences and the adults who allowed them to transition in a Tuesday Substack article by Suzy Weiss.
The women, sometimes referred to as “detransitioners,” were given extreme biomedical interventions ranging from hormones and puberty blockers to double mastectomies in adolescence to relieve their gender dysphoria, according to the article. Several blamed the adults in their lives for failing them.